AI Index / Schrödinger, Inc.
Schrödinger, Inc. (SDGR)
Schrödinger, a company specializing in computational platforms for molecular discovery, integrates advanced machine learning into its software to enhance drug discovery processes. This includes initiatives like predictive toxicology, supported by a $10 million grant from the Gates Foundation, aiming to anticipate toxicological risks early in drug development.
Loading...
Our industry-leading computation platform combines proven physics-based methods with the speed of machine learning to accelerate molecular discovery.
- Ramy Farid
Similar Companies in the Swift AI Index
Quotes from schrdinger Executives About Artificial Intelligence and Generative AI
The collaboration is also associated with a significant multi-year software contract that substantially increases Novartis’ access to our technology.
- Geoff Porges
We are seeing increased demand for these combination drug discovery-software arrangements that leverage synergies between different components of our business.
- Ramy Farid
This partnership is emblematic of our business development and translational science strategy to leverage the extensive capabilities and experience of specific partners to advance and maximize the potential of certain proprietary programs.
- Karen Akinsanya